• Status of the Device Tax

    On January 22, Congress passed and the President signed into law a government funding bill that included a two-year suspension of the 2.3% excise tax on the sale of medical devices.. The tax, first enacted as part of the Affordable Care Act (ACA), had taken effect January 1, 2018, after Congress did not extend a moratorium on the tax that expired at the end of 2017. This latest action delays the tax for 2018 and 2019, retroactive to January 1. BioUtah and its member companies continue to push for a permanent repeal of the tax.